DENALI THERAPEUTICS INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.52 USD | -1.65% |
|
+9.75% | -4.52% |
| 05-08 | Stifel Adjusts Price Target on Denali Therapeutics to $22 From $26, Maintains Hold Rating | MT |
| 05-08 | Wedbush Adjusts Denali Therapeutics' Price Target to $30 From $31, Keeps Outperform Rating | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DENALI THERAPEUTICS INC. | Bio Therapeutic Drugs | -1.73% | +9.75% | -4.52% | -30.07% | -0.92% | 2.97B |  |  |  |
- Stock Market
- Equities
- DNLI Stock
- Charts Denali Therapeutics Inc.
- Relative Strength Chart